170 related articles for article (PubMed ID: 29846820)
1. Whole exome sequencing in Dandy-Walker variant with intellectual disability reveals an activating CIP2A mutation as novel genetic cause.
Yang CA; Chou IC; Cho DY; Lin CY; Huang HY; Ho YC; Liu TY; Li YH; Chang JG
Neurogenetics; 2018 Aug; 19(3):157-163. PubMed ID: 29846820
[TBL] [Abstract][Full Text] [Related]
2. Prenatal whole exome sequencing detects a new homozygous fukutin (FKTN) mutation in a fetus with an ultrasound suspicion of familial Dandy-Walker malformation.
Traversa A; Bernardo S; Paiardini A; Giovannetti A; Marchionni E; Genovesi ML; Guadagnolo D; Torres B; Paolacci S; Bernardini L; Mazza T; Carella M; Caputo V; Pizzuti A
Mol Genet Genomic Med; 2020 Jan; 8(1):e1054. PubMed ID: 31756055
[TBL] [Abstract][Full Text] [Related]
3. CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation.
Puustinen P; Rytter A; Mortensen M; Kohonen P; Moreira JM; Jäättelä M
J Cell Biol; 2014 Mar; 204(5):713-27. PubMed ID: 24590173
[TBL] [Abstract][Full Text] [Related]
4. CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer.
Lei N; Peng B; Zhang JY
Oncol Rep; 2014 Oct; 32(4):1689-94. PubMed ID: 25109354
[TBL] [Abstract][Full Text] [Related]
5. Usher syndrome associated with a variant of Dandy-Walker malformation.
Simsek T; Ozdamar Y; Simsek E; Men G
J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214164
[TBL] [Abstract][Full Text] [Related]
6. CIP2A inhibits PP2A in human malignancies.
Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
[TBL] [Abstract][Full Text] [Related]
7. Missense variant in CCDC22 causes X-linked recessive intellectual disability with features of Ritscher-Schinzel/3C syndrome.
Kolanczyk M; Krawitz P; Hecht J; Hupalowska A; Miaczynska M; Marschner K; Schlack C; Emmerich D; Kobus K; Kornak U; Robinson PN; Plecko B; Grangl G; Uhrig S; Mundlos S; Horn D
Eur J Hum Genet; 2015 May; 23(5):633-8. PubMed ID: 24916641
[TBL] [Abstract][Full Text] [Related]
8. KIAA1524/CIP2A promotes cancer growth by coordinating the activities of MTORC1 and MYC.
Puustinen P; Jäättelä M
Autophagy; 2014 Jul; 10(7):1352-4. PubMed ID: 24905455
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.
Jung HM; Patel RS; Phillips BL; Wang H; Cohen DM; Reinhold WC; Chang LJ; Yang LJ; Chan EK
Mol Biol Cell; 2013 Jun; 24(11):1638-48, S1-7. PubMed ID: 23552692
[TBL] [Abstract][Full Text] [Related]
10. X-linked inheritance of Dandy-Walker variant.
Wakeling EL; Jolly M; Fisk NM; Gannon C; Holder SE
Clin Dysmorphol; 2002 Jan; 11(1):15-8. PubMed ID: 11822699
[TBL] [Abstract][Full Text] [Related]
11. CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.
Niemelä M; Kauko O; Sihto H; Mpindi JP; Nicorici D; Pernilä P; Kallioniemi OP; Joensuu H; Hautaniemi S; Westermarck J
Oncogene; 2012 Sep; 31(39):4266-78. PubMed ID: 22249265
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of cancerous inhibitor of PP2A (CIP2A) in bone marrow cells from patients with a group of high-risk myelodysplastic syndromes.
Li N; Abe S; Kurata M; Abe-Suzuki S; Onishi I; Kirimura S; Murayama T; Hidaka M; Kawano F; Kitagawa M
Pathol Oncol Res; 2014 Apr; 20(2):399-407. PubMed ID: 24163288
[TBL] [Abstract][Full Text] [Related]
13. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
[TBL] [Abstract][Full Text] [Related]
14. Dandy-Walker malformation, genitourinary abnormalities, and intellectual disability in two families.
Zaki MS; Masri A; Gregor A; Gleeson JG; Rosti RO
Am J Med Genet A; 2015 Nov; 167A(11):2503-2507. PubMed ID: 26109232
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Joubert Syndrome 10 in a Fetus with Suspected Dandy-Walker Variant by WES: A Novel Splicing Mutation in
Linpeng S; Liu J; Pan J; Cao Y; Teng Y; Liang D; Li Z; Wu L
Biomed Res Int; 2018; 2018():4032543. PubMed ID: 30581852
[TBL] [Abstract][Full Text] [Related]
16. Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.
Jeong AL; Lee S; Park JS; Han S; Jang CY; Lim JS; Lee MS; Yang Y
J Biol Chem; 2014 Jan; 289(1):28-40. PubMed ID: 24214971
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
[TBL] [Abstract][Full Text] [Related]
18. Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.
Wang J; Okkeri J; Pavic K; Wang Z; Kauko O; Halonen T; Sarek G; Ojala PM; Rao Z; Xu W; Westermarck J
EMBO Rep; 2017 Mar; 18(3):437-450. PubMed ID: 28174209
[TBL] [Abstract][Full Text] [Related]
19. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.
Janghorban M; Farrell AS; Allen-Petersen BL; Pelz C; Daniel CJ; Oddo J; Langer EM; Christensen DJ; Sears RC
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9157-62. PubMed ID: 24927563
[TBL] [Abstract][Full Text] [Related]
20. Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.
Khanna A; Kauko O; Böckelman C; Laine A; Schreck I; Partanen JI; Szwajda A; Bormann S; Bilgen T; Helenius M; Pokharel YR; Pimanda J; Russel MR; Haglund C; Cole KA; Klefström J; Aittokallio T; Weiss C; Ristimäki A; Visakorpi T; Westermarck J
Cancer Res; 2013 Nov; 73(22):6757-69. PubMed ID: 24072747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
